These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
203 related articles for article (PubMed ID: 33693653)
1. Incidence and Predictors of Hypertension in a Cohort of Australian Women With and Without Polycystic Ovary Syndrome. Joham AE; Kakoly NS; Teede HJ; Earnest A J Clin Endocrinol Metab; 2021 May; 106(6):1585-1593. PubMed ID: 33693653 [TBL] [Abstract][Full Text] [Related]
2. The Impact of Obesity on the Incidence of Type 2 Diabetes Among Women With Polycystic Ovary Syndrome. Kakoly NS; Earnest A; Teede HJ; Moran LJ; Joham AE Diabetes Care; 2019 Apr; 42(4):560-567. PubMed ID: 30705063 [TBL] [Abstract][Full Text] [Related]
3. Hypertension in Reproductive-Aged Women With Polycystic Ovary Syndrome and Association With Obesity. Joham AE; Boyle JA; Zoungas S; Teede HJ Am J Hypertens; 2015 Jul; 28(7):847-51. PubMed ID: 25542625 [TBL] [Abstract][Full Text] [Related]
4. Gestational diabetes and type 2 diabetes in reproductive-aged women with polycystic ovary syndrome. Joham AE; Ranasinha S; Zoungas S; Moran L; Teede HJ J Clin Endocrinol Metab; 2014 Mar; 99(3):E447-52. PubMed ID: 24081730 [TBL] [Abstract][Full Text] [Related]
5. Predictors of hypertensive disorders in pregnancy in women with and without polycystic ovary syndrome: The Australian Longitudinal Study of Women's Health. Bahri Khomami M; Earnest A; Loxton D; Teede HJ; Joham AE Clin Endocrinol (Oxf); 2021 Aug; 95(2):323-331. PubMed ID: 33639011 [TBL] [Abstract][Full Text] [Related]
6. Progression of glucose intolerance and cardiometabolic risk factors over a decade in Chinese women with polycystic ovary syndrome: A case-control study. Ng NYH; Jiang G; Cheung LP; Zhang Y; Tam CHT; Luk AOY; Quan J; Lau ESH; Yau TTL; Chan MHM; Ho CS; Lim CKP; Ozaki R; Huang J; Liu KH; Tam WH; Sahota DS; Chu WCW; Goggins W; Woo J; Li TC; Chow CC; Chan JCN; Ma RCW PLoS Med; 2019 Oct; 16(10):e1002953. PubMed ID: 31652273 [TBL] [Abstract][Full Text] [Related]
7. Risk of type 2 diabetes is increased in nonobese women with polycystic ovary syndrome: the National Health Insurance Service-National Sample Cohort Study. Ryu KJ; Kim MS; Kim HK; Kim YJ; Yi KW; Shin JH; Hur JY; Kim T; Park H Fertil Steril; 2021 Jun; 115(6):1569-1575. PubMed ID: 33509630 [TBL] [Abstract][Full Text] [Related]
8. Self-Reported Polycystic Ovary Syndrome Is Associated With Hypertension: A Northern Finland Birth Cohort 1966 Study. Ollila ME; Kaikkonen K; Järvelin MR; Huikuri HV; Tapanainen JS; Franks S; Piltonen TT; Morin-Papunen L J Clin Endocrinol Metab; 2019 Apr; 104(4):1221-1231. PubMed ID: 30445634 [TBL] [Abstract][Full Text] [Related]
9. Prevalence of infertility and use of fertility treatment in women with polycystic ovary syndrome: data from a large community-based cohort study. Joham AE; Teede HJ; Ranasinha S; Zoungas S; Boyle J J Womens Health (Larchmt); 2015 Apr; 24(4):299-307. PubMed ID: 25654626 [TBL] [Abstract][Full Text] [Related]
10. Incidence and prevalence of diabetes and cost of illness analysis of polycystic ovary syndrome: a Bayesian modelling study. Ding T; Hardiman PJ; Petersen I; Baio G Hum Reprod; 2018 Jul; 33(7):1299-1306. PubMed ID: 29684121 [TBL] [Abstract][Full Text] [Related]
12. Higher risk of type 2 diabetes in women with hyperandrogenic polycystic ovary syndrome. Persson S; Elenis E; Turkmen S; Kramer MS; Yong EL; Poromaa IS Fertil Steril; 2021 Sep; 116(3):862-871. PubMed ID: 34053678 [TBL] [Abstract][Full Text] [Related]
13. The contribution of diet, physical activity and sedentary behaviour to body mass index in women with and without polycystic ovary syndrome. Moran LJ; Ranasinha S; Zoungas S; McNaughton SA; Brown WJ; Teede HJ Hum Reprod; 2013 Aug; 28(8):2276-83. PubMed ID: 23771201 [TBL] [Abstract][Full Text] [Related]
14. Cardiovascular disease in a nationwide population of Danish women with polycystic ovary syndrome. Glintborg D; Rubin KH; Nybo M; Abrahamsen B; Andersen M Cardiovasc Diabetol; 2018 Mar; 17(1):37. PubMed ID: 29519249 [TBL] [Abstract][Full Text] [Related]
15. Contraception use and pregnancy outcomes in women with polycystic ovary syndrome: data from the Australian Longitudinal Study on Women's Health. Joham AE; Boyle JA; Ranasinha S; Zoungas S; Teede HJ Hum Reprod; 2014 Apr; 29(4):802-8. PubMed ID: 24549213 [TBL] [Abstract][Full Text] [Related]
16. Increased prevalence of eating disorders, low self-esteem, and psychological distress in women with polycystic ovary syndrome: a community-based cohort study. Tay CT; Teede HJ; Hill B; Loxton D; Joham AE Fertil Steril; 2019 Aug; 112(2):353-361. PubMed ID: 31056307 [TBL] [Abstract][Full Text] [Related]
17. Longitudinal weight gain in women identified with polycystic ovary syndrome: results of an observational study in young women. Teede HJ; Joham AE; Paul E; Moran LJ; Loxton D; Jolley D; Lombard C Obesity (Silver Spring); 2013 Aug; 21(8):1526-32. PubMed ID: 23818329 [TBL] [Abstract][Full Text] [Related]
18. Risk of cardiocerebrovascular diseases is increased in Korean women with polycystic ovary syndrome: a nationwide cohort study. Ryu KJ; Park H; Kim MS; Jeong HG; Kim T Sci Rep; 2024 Jan; 14(1):1055. PubMed ID: 38212642 [TBL] [Abstract][Full Text] [Related]
19. Increased COVID-19 infections in women with polycystic ovary syndrome: a population-based study. Subramanian A; Anand A; Adderley NJ; Okoth K; Toulis KA; Gokhale K; Sainsbury C; O'Reilly MW; Arlt W; Nirantharakumar K Eur J Endocrinol; 2021 May; 184(5):637-645. PubMed ID: 33635829 [TBL] [Abstract][Full Text] [Related]
20. Risk of developing major depressive disorder in polycystic ovary syndrome: a retrospective cohort study. Lee IO; Kim JC; Seo JW; Pak HY; Chung JE J Obstet Gynaecol; 2021 Oct; 41(7):1157-1161. PubMed ID: 33645403 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]